An Analysis of the Assessment of Glycated Hemoglobin Using A1cNow+™ Point-of-Care Device Compared to Central Laboratory Testing—an Important Addition to Pharmacist-Managed Diabetes Programs?

Abstract

The diabetes epidemic is accelerating rapidly. If no progress is made in early detection, then early intervention and treatment-to-goal diabetes care will become an overwhelming burden on our health care system. Better utilization of self-monitoring of blood glucose in patients with type 2 diabetes not on insulin could be achieved with regular review of hemoglobin A1c (A1C) values. Educating patients about the importance of diet, exercise, and medication compliance is enhanced when evidence of average blood glucose control can be presented to the patient directly. Affordable, accurate point-of-care testing of A1C with A1cNow+™ (Bayer HealthCare, Terrytown, NY) utilized in pharmacist-managed outpatient diabetes programs may prove to be an important clinical tool for improving patient outcomes and reducing the cost of the expanding diabetes epidemic.

Keywords

cost diabetes fitness hemoglobin A1c nutrition pharmacist point of care type 2 diabetes

References

Number of People with Diabetes Increases to 24 Million. http://www.cdc.gov/media/pressrel/2008/r080624.htm. Accessed July 27, 2008.

Cranor

Bunting

Christensen

. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43 (2): 173–84.

Lindsey

Carter

Mangum

Greene

Richardson

Brown

McCandless

. A prospective, randomized multi-centered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care. Diabetes Technol Ther. 2004;6 (3): 370–7.

Heisler

Piette

Spencer

Kieffer

Vijan

. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care. 2005;28 (4): 816–22.

Standards of Medical Care in Diabetes—2007. http://care.diabetesjournals.org/cgi/content/full/30/suppl_1/S4. Accessed July 27, 2008.

Klonoff

. New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 diabetes—when this practice is not applied properly. J Diabetes Sci Technol. 2008;2 (3): 342–8.

Towfigh

Romanova

Weinreb

Munjas

Suttorp

Zhou

Shekelle

. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a metaanalysis. Am J.

National Diabetes Fact Sheet 2007. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf. Accessed July 27, 2008.

Stewart

May

Allen

Bathalon

Lavergne

Sigrist

Ryan

Williamson

. Development of an Internet/population-based weight management program for the U.S. Army. J Diabetes Sci Technol. 2008;2 (1): 116–26.

10.

Carter

Borchardt

Cooney

Greene

. Dual test diabetes screening project: screening for poor glycemic control in a large workplace population. Diabetes Technol Ther. 2000;2 (4): 529–36.

11.

Arrendale

Cherian

Zineh

Chirico

Taylor

. Assessment of glucated hemoglobin using A1CNow+TM point-of-care device as compared to central laboratory testing. J Diabetes Sci Technol. 2008;2 (5): 822–827.